These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3536528

  • 21. Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma.
    Mizuno H, Yamao H, Nagura E, Shimizu K, Kamiya O, Takeyama H, Nitta M, Wakita A, Ichikawa A, Kobayashi M, Kawashima K, Saito H, Nagoya Myeloma Cooperative Study Group.
    Intern Med; 2002 Apr; 41(4):290-4. PubMed ID: 11993789
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden.
    Osterborg A, Björkholm M, Björeman M, Brenning G, Carlson K, Celsing F, Gahrton G, Grimfors G, Gyllenhammar H, Hast R.
    Blood; 1993 Mar 15; 81(6):1428-34. PubMed ID: 8453092
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone.
    Baldini L, Radaelli F, Chiorboli O, Fumagalli S, Cro L, Segala M, Cesana BM, Polli EE, Maiolo AT.
    Cancer; 1991 Jul 01; 68(1):62-7. PubMed ID: 2049754
    [Abstract] [Full Text] [Related]

  • 30. [Erythropoietin in multiple myeloma].
    Pecherstorfer M, Schmoranzer F, Vesely M, Fortelny A, Baumgartner G.
    Dtsch Med Wochenschr; 1990 Jul 13; 115(28-29):1096-9. PubMed ID: 2373040
    [Abstract] [Full Text] [Related]

  • 31. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM, Harrington DP, Abramson N, Kyle RA, Knospe W, Glick JH.
    Cancer; 1997 Apr 15; 79(8):1561-7. PubMed ID: 9118039
    [Abstract] [Full Text] [Related]

  • 32. Results and further perspectives of plasmocytoma chemotherapy.
    Sakalová A, Hrubisko M, Gazová S, Steruská M, Prümmerová J.
    Neoplasma; 1986 Apr 15; 33(2):251-8. PubMed ID: 3520353
    [Abstract] [Full Text] [Related]

  • 33. Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma.
    Bachleitner-Hofmann T, Machold K, Knobler R, Drach J, Grumbeck E, Gisslinger H.
    Clin Exp Rheumatol; 2002 Apr 15; 20(1):85-8. PubMed ID: 11892717
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology).
    Bladé J, San Miguel JF, Escudero ML, Fontanillas M, Besalduch J, Gardella S, Arias J, García-Conde J, Carnero M, Marti JM, Rozman C, Estapé J, Montserrat E.
    Leukemia; 1998 Jul 15; 12(7):1144-8. PubMed ID: 9665202
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.